Imovax Polio, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv poliomijelitisa, inaktivirano
Name | Imovax Polio, suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv poliomijelitisa, inaktivirano |
---|---|
Marketing Authorisation Number | HR-H-527075219 |
Active Substance | poliovirus tip 1, soj Mahoney (inaktiviran) poliovirus tip 2, soj MEF-1 (inaktiviran) poliovirus tip 3, soj Saukett (inaktiviran) |
Composition | 1 doza (0,5 ml) sadržava: Poliovirus tip 1 Mahoney soj (inaktiviran): 29 D antigen jedinica, Poliovirus tip 2 MEF-1 soj (inaktiviran): 7 D antigen jedinica, Poliovirus tip 3 Saukett soj (inaktiviran): 26 D antigen jedinica |
Pharmaceutical Form | suspenzija za injekciju u napunjenoj štrcaljki |
Packaging [MA Number for Packaging] | 1 napunjena štrcaljka s 0,5 ml suspenzije, u kutiji [HR-H-527075219-01] |
Manufacturer | Sanofi Pasteur, Lyon, Francuska
Sanofi-Aventis Zrt., Budimpešta, Mađarska |
Marketing Authorisation Holder | Sanofi Pasteur, 14 Espace Henry Vallee, Lyon, Francuska |
Marketing Authorisation Date | 20.01.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/18-02/147 |
Registration Number | 381-12-01/38-20-05 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | J07BF03 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |